Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Al Borg Diagnostics is the largest chain of private medical laboratories in the Gulf Cooperation Council (GCC) region, headquartered in Saudi Arabia. Established in 1998, the company provides a comprehensive suite of diagnostic services, including routine clinical testing, specialized molecular diagnostics, and advanced genomic sequencing. It operates a vast network of over 70 laboratories across eight countries, serving hospitals, clinics, and millions of individual patients annually. The company is recognized for its commitment to international quality standards, holding prestigious accreditations from the College of American Pathologists (CAP) and ISO. Beyond traditional diagnostics, Al Borg has expanded into personalized medicine and wellness through its "Blueprint" program, which focuses on preventive health and lifestyle management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Al Borg Medical Laboratories.